ORLANDO, FL, USA (UroToday.com) - Studies have suggested a prognostic role for p53 in patients with urothelial carcinoma (UC) of the bladder.
Your session will expire in 8 hours requiring you to log in each day to view content.
Browse Categories
ASCO 2009 - Randomized Trial of p53 Targeted Adjuvant Therapy for Patients with Organ-Confined Node-Negative Urothelial Bladder Cancer - Session Highlights
Your session will expire in 8 hours requiring you to log in each day to view content.